Research Focus: Targeting the MCL-1 Pathway With CDK9 Inhibitors in AML

In this slideset and commentary I explore the novel approach of inhibiting CDK9 as a way of downregulating MCL-1 and thereby minimizing survival signals in AML cells.

Share

Program Content

Activities

Targeting MCL-1 in AML
Research Focus: Targeting the MCL-1 Pathway With CDK9 Inhibitors in AML
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 03, 2019

Expires: May 02, 2020

Faculty

cover img faculity

Eunice S. Wang, MD

Chief, Leukemia/Benign Hematology Service
Professor of Oncology
Roswell Park Comprehensive Cancer Center
Buffalo, New York

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Boston Biomedical